heartflow.comHealthcare / Healthcare providers & servicesFounded: 2007Funding to Date: $528.72MM
HeartFlow is revolutionizing precision heart care, combining human ingenuity with advanced AI technology. They began their journey to improve coronary artery disease diagnosis with FFRCT and have now expanded their product portfolio to include anatomic stenosis and plaque information. This company was founded by Charles Taylor, Christopher Zarins, and John Stevens in 2007 and is headquartered in Redwood City, CA.
Funding Date | Share Class | Amount Raised | Price per Share | Post-Money Valuation | Key Investors | |
---|---|---|---|---|---|---|
06/13/2019 | Series E | $305MM | $xx.xx | $1.65B | Wellington Management, Baillie Gifford | |
Price per Share
$xx.xx
Shares Outstanding
13,422,649
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
Wellington Management, Baillie Gifford
|
||||||
05/10/2016 | Series D | $99.93MM | $xx.xx | $771.66MM | Panorama Point Partners, BlueCross BlueShield Venture Partners, undisclosed investors | |
Price per Share
$xx.xx
Shares Outstanding
7,151,873
Liquidation Pref Order
2
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
Panorama Point Partners, BlueCross BlueShield Venture Partners, undisclosed investors
|
||||||
02/26/2014 | Series C | $104.7MM | $xx.xx | $373.44MM | Sandbox Industries, HealthCor Management, Capricorn Investment Group, undisclosed investors | |
Price per Share
$xx.xx
Shares Outstanding
11,343,434
Liquidation Pref Order
3
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
Sandbox Industries, HealthCor Management, Capricorn Investment Group, undisclosed investors
|
||||||
02/04/2011 | Series B-2 | $10.11MM | $xx.xx | $90.13MM | HealthCor Partners Management, GE Ventures, undisclosed investors | |
Price per Share
$xx.xx
Shares Outstanding
2,848,263
Liquidation Pref Order
3
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
HealthCor Partners Management, GE Ventures, undisclosed investors
|
||||||
02/04/2011 | Series B-1 | $6.94MM | $xx.xx | $90.13MM | HealthCor Partners Management, GE Ventures, undisclosed investors | |
Price per Share
$xx.xx
Shares Outstanding
1,954,846
Liquidation Pref Order
4
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
HealthCor Partners Management, GE Ventures, undisclosed investors
|
||||||
04/16/2010 | Series A | $2.04MM | $xx.xx | $8.17MM | Emergent Medical Partners, U.S. Venture Partners, BlueCross BlueShield Venture Partners, Capricorn Healthcare, Special Opportunities | |
Price per Share
$xx.xx
Shares Outstanding
4,082,965
Liquidation Pref Order
5
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
6.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
Emergent Medical Partners, U.S. Venture Partners, BlueCross BlueShield Venture Partners, Capricorn Healthcare, Special Opportunities
|